Key Takeaways Shares of Solventum rose Tuesday after the company agreed to sell its filtration and purification business to ...

M health care spinoff Solventum is selling its purification business to Thermo Fisher Scientific for $4.1 billion in cash to ...

Companies confirm deal details. Thermo Fisher Scientific (NYSE:TMO) confirmed that it agreed to purchase Solventum's ...

The addition of Solventum’s business provides a strategic fit with Thermo Fisher and will create value for customers, according to Marc N. Casper, chairman, president, and CEO of Thermo Fisher.

GlobalData analyst Dr Andrew S Thompson expects the deal to prompt a "shuffle" in Thermo Fisher’s life sciences unit.

Solventum surpassed fourth-quarter revenue and earnings expectations while facing challenges in segments and regulatory ...

Solventum (NYSE: SOLV) today announced it has entered into a definitive agreement to sell its Purification & Filtration1 ...

Waltham-based Thermo is buying the business from Solventum, a Minnesota-based company that spun off from manufacturing ...

Solventum Corp., 3M’s medtech spinoff, has sold its purification and filtration business to Massachussetts-based Thermo ...

Shares in Solventum rallied after Thermo Fisher Scientific said it would buy the healthcare company's purification and filtration business for about $4.1 billion. Solventum was spun off from 3M last ...

Contract drug manufacturer Thermo Fisher Scientific said on Tuesday it will buy Solventum's purification and filtration ...

Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that the company has entered into a ...